JPMorgan Chase & Co’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4M | Buy |
|
|||||
|
2025
Q1 | $26.5M | Buy |
|
|||||
|
2024
Q4 | $2.32M | Sell |
|
|||||
|
2024
Q3 | $3.65M | Buy |
|
|||||
|
2024
Q2 | $3.44M | Buy |
|
|||||
|
2024
Q1 | $1.54M | Buy |
|
|||||
|
2023
Q4 | $552K | Sell |
|
|||||
|
2023
Q3 | $3.03M | Buy |
|
|||||
|
2023
Q2 | $401K | Buy |
|
|||||
|
2023
Q1 | $309K | Buy |
|
|||||
|
2022
Q4 | $237K | Sell |
|
|||||
|
2022
Q3 | $557K | Buy |
|
|||||
|
2022
Q2 | $242K | Buy |
|
|||||
|
2022
Q1 | $268K | Sell |
|
|||||
|
2021
Q4 | $450K | Sell |
|
|||||
|
2021
Q3 | $1.52M | Buy |
|
|||||
|
2021
Q2 | $334K | Buy |
|
|||||
|
2021
Q1 | $158K | Buy |
|
|||||
|
2020
Q4 | $134K | Buy |
|